Newbury Pharmaceuticals AB (OSTO:NEWBRY) Asset Impairment Charge : kr0.00 Mil (TTM As of Feb. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB Asset Impairment Charge?

Newbury Pharmaceuticals AB's Asset Impairment Charge for the three months ended in Feb. 2025 was kr0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Feb. 2025 was kr0.00 Mil.

Newbury Pharmaceuticals AB Asset Impairment Charge Historical Data

The historical data trend for Newbury Pharmaceuticals AB's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB Asset Impairment Charge Chart

Newbury Pharmaceuticals AB Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Asset Impairment Charge

Newbury Pharmaceuticals AB Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Asset Impairment Charge	Get a 7-Day Free Trial													-	-	-	-	-

Newbury Pharmaceuticals AB Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Newbury Pharmaceuticals AB Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.newburypharma.com

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB Headlines

No Headlines